kaonavi
4435
D. Western Therapeutics Institute
4576
Itamiarts
168A
Nakayo
6715
Allied Telesis Holdings KK
6835
JP Stock MarketDetailed Quotes
1808 HASEKO
- 2044.0
- -8.5-0.41%
20min DelayNot Open Feb 18 15:30 JST
614.82BMarket Cap9.95P/E (Static)
2054.5High2020.0Low982.90KVolume2051.0Open2052.5Pre Close2.00BTurnover2081.052wk High0.51%Turnover Ratio300.79MShares1575.052wk Low127.57EPS TTM394.75BFloat Cap2490.0Historical High9.95P/E (Static)193.12MShs Float155.0Historical Low205.45EPS LYR1.68%Amplitude85.00Dividend TTM1.10P/B100Lot Size4.16%Div YieldTTM
HASEKO News
HASEKO: Notice regarding the formulation of the “Haseko Group Mid-Term Management Plan”
HASEKO: Notice Concerning Formulating the "HASEKO Group Medium-Term Business Plan"
HASEKO: Notice Concerning Determination of Matters Related to Acquisition of Own Shares
HASEKO: Notice Concerning Recording of Extraordinary Losses (Impairment Losses) and Revisions to Full-Year Financial Results Forecasts
HASEKO: Summary of Financial Statements for the nine months ended December 31,2024
HASEKO: Consolidated Financial Results for the Nine Months Ended December 31,2024
HASEKO: Notice Concerning Change of President
HASEKO: Corporate Governance Report
HASEKO: Summary of Financial Statements for the six months ended September 30,2024
HASEKO: Consolidated Financial Results for the Six Months Ended September 30,2024
HASEKO: Haseko Group Integrated Report 2024
HASEKO: Notice regarding publication of the “Haseko Group Integrated Report 2024”
HASEKO: Summary of financial statements for the 3-month period ending on June 30, 2024.
HASEKO: Consolidated financial results for the three-month period ending on June 30, 2024.
HASEKO: Corporate Governance Report
HASEKO: Independent Company Executives Declaration
HASEKO: Consolidated financial results for the year ended March 31, 2024
HASEKO: CORPORATE GOVERNANCE REPORT
HASEKO: Summary of financial statements for the year ended March 31, 2024
HASEKO: Notice regarding dividends from surplus funds